Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125402001 | 12540200 | 1 | I | 201510 | 20151020 | 20160708 | 20160708 | EXP | US-BIOGEN-2015BI139154 | BIOGEN | 58.44 | YR | F | Y | 61.29000 | KG | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125402001 | 12540200 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | POWDER FOR SOLUTION FOR INJECTION | ||||||||
| 125402001 | 12540200 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | |||||||
| 125402001 | 12540200 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | POWDER FOR SOLUTION FOR INJECTION | /wk | |||||||
| 125402001 | 12540200 | 4 | C | vitamin d 3 | 2 | Unknown | 0 | 1000 | IU | TABLETS | QD | ||||||||
| 125402001 | 12540200 | 5 | C | calcium 600 | 2 | Unknown | 0 | 600 | MG | TABLETS | QD | ||||||||
| 125402001 | 12540200 | 6 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLETS | BID | |||||||
| 125402001 | 12540200 | 7 | C | oxybutyn | 2 | Unknown | 0 | 5 | MG | TABLETS | QD | ||||||||
| 125402001 | 12540200 | 8 | C | ADVIL | IBUPROFEN | 1 | Unknown | 0 | 500 | MG | TABLETS | BID | |||||||
| 125402001 | 12540200 | 9 | C | MODAFINIL. | MODAFINIL | 1 | Oral | 0 | 200 | MG | TABLETS | QD | |||||||
| 125402001 | 12540200 | 10 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | TAKEN AS NECESSARY FOR NAUSEA | 0 | UNKNOWN | |||||||||
| 125402001 | 12540200 | 11 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125402001 | 12540200 | 1 | Multiple sclerosis |
| 125402001 | 12540200 | 4 | Product used for unknown indication |
| 125402001 | 12540200 | 5 | Product used for unknown indication |
| 125402001 | 12540200 | 6 | Product used for unknown indication |
| 125402001 | 12540200 | 7 | Neurogenic bladder |
| 125402001 | 12540200 | 8 | Product used for unknown indication |
| 125402001 | 12540200 | 9 | Product used for unknown indication |
| 125402001 | 12540200 | 10 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125402001 | 12540200 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125402001 | 12540200 | Balance disorder | |
| 125402001 | 12540200 | Glioblastoma multiforme | |
| 125402001 | 12540200 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125402001 | 12540200 | 1 | 199811 | 0 | ||
| 125402001 | 12540200 | 2 | 19981101 | 0 | ||
| 125402001 | 12540200 | 3 | 201411 | 0 |